The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
NLRP3 inflammasome and its inhibitors: a review
Open accessAbstract
Inflammasomes are newly recognized, vital players in innate immunity. The best characterized is the NLRP3 inflammasome, so-called because the NLRP3 protein in the complex belongs to the family of nucleotide-binding and oligomerization domain-like receptors (NLRs) and is also known as "pyrin domain-containing protein 3". The NLRP3 inflammasome is associated with onset and progression of various diseases, including metabolic disorders, multiple sclerosis, inflammatory bowel disease, cryopyrin-associated periodic fever syndrome, as well as other auto-immune and auto-inflammatory diseases. Several NLRP3 inflammasome inhibitors have been described, some of which show promise in the clinic. The present review will describe the structure and mechanisms of activation of the NLRP3 inflammasome, its association with various auto-immune and auto-inflammatory diseases, and the state of research into NLRP3 inflammasome inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, it has been demonstrated that NF‐κB–mediated signaling is also involved in the NLRP3 inflammasome activation by regulating the transcription of inflammasome‐related components, including inactive NLRP3, pro‐IL‐1β, and pro‐IL‐18.46”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“These endogenous non-coding RNAs are 20– 23 nt long and bind to the 3′ untranslated region (3′ UTR) of protein-coding mRNAs to regulate their translation (Bartel, 2009; Chen and Sun, 2013).”
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 1×
“A newly identified PRR, first described in detail in 2002, is the inflammasome (Martinon et al., 2002; Gentile et al., 2015; Jorgensen and Miao, 2015; Sanders et al., 2015).”
BackgroundSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · cited 3×
“Formation of the inflammasome also triggers a process of inflammation-related cell death termed pyroptosis (Willingham et al., 2009; Schroder and Tschopp, 2010; Zhong et al., 2013a; Jorgensen and Miao, 2015).”
BackgroundMethodInflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“…protect against disease and death, inappropriate activation of the NLRP3 inflammasome can contribute to the onset and progression of various diseases, particularly age-related diseases such as metabolic disorders and metabolic syndrome (Franceschi et al., 2000; Goldberg and Dixit, 2015).”
BackgroundNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 1×
“…in macrophages and animal models have shown that oxidized low-density lipoprotein and cholesterol crystals trigger NLRP3 inflammasome activation (Duewell et al., 2010; Liu et al., Frontiers in Pharmacology | www.frontiersin.org 2 November 2015 | Volume 6 | Article 262 FIGURE 1 | Schematic…”
BackgroundBauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087 · cited 1×
“…PAMPs or DAMPs are recognized by TLRs, leading to activation of nuclear factor kappa B (NF-κB)-mediated signaling, which in turn up-regulates transcription of inflammasome-related components, including inactive NLRP3, proIL-1β, and proIL18 (Bauernfeind et al., 2009; Franchi et al., 2012, 2014).”
BackgroundHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065 · cited 2×
“…damage or dysfunction caused by mitochondrial Ca2+ overload (Iyer et al., 2013; Miao et al., 2014; Zhuang et al., 2015), lysosomal disruption (Hornung et al., 2008; Sheedy et al., 2013; Tseng et al., 2013), autophagic dysfunction (Cho et al., 2014; Shao et al., 2014; Jabir et al., 2015) and…”
BackgroundA small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849 · cited 3×
“Coll et al. (2015) discovered that MCC950, a diarylsulfonylurea-containing compound known to inhibit caspase-1-dependent processing of IL-1β (Perregaux et al., 2001), also inhibits both canonical and non-canonical activation of the NLRP3 inflammasome.”
BackgroundThe ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172 · cited 2×
“Youm et al. (2015) discovered that the ketone metabolite β-hydroxybutyrate (BHB), but not acetoacetate or the shortchain fatty acids butyrate and acetate, reduced IL-1β, and IL-18 production by the NLRP3 inflammasome in human monocytes.”
BackgroundNuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M. G., Langford, T. K. A., Bucks, C. M., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 2,079
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 838
Wen, C., Wang, J., Sun, Z., Zhong, R., Li, M., Shen, X., Ye, Q., Qin, K., & Peng, X. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03715-y · Cited by 23
“NLRP3 activates Caspase-1, and then induces the production and secretion of IL-1β and IL-18, which causes an inflammatory response [52].”
He, K.-L., Yu, X., Xia, L., Xie, Y., Qi, E., Wan, L., Hua, X., & Jing, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526786 · Cited by 25
PI3K/AKT pathway: A potential therapeutic target in cerebral ischemia-reperfusion injury
Han, Y., Sun, Y., Peng, S., Tang, T., Zhang, B., Yu, R., Sun, X., Guo, S., Ma, L., Li, P., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177505 · Cited by 27
Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link
Saha, B., Banerjee, A., Pathak, R., Duttaroy, A. K., & Pathak, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118592 · Cited by 25
Celias, D. P., Corvo, I., Silvane, L., Tort, J. F., Chiapello, L. S., Fresno, M., Arranz, A., Motrán, C. C., & Cervi, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00552 · Cited by 23
Nishiguchi, T., Iwata, M., Kajitani, N., Miura, A., Matsuo, R., Murakami, S., Nakada, Y., Pu, S., Shimizu, Y., Tsubakino, T., et al. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12164 · Cited by 24
Batsukh, S., Oh, S., Rheu, K.-M., Lee, B.-J., Park, C. H., Son, K. H., & Byun, K. (2022) · Nutrients · doi:10.3390/nu14245382 · Cited by 25
Caruso, G., Pietro, L. D., & Caraci, F. (2023) · Biomolecules · doi:10.3390/biom13030505 · Cited by 24
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
Pérez‐Gómez, J. M., Montero‐Hidalgo, A. J., Fuentes-Fayos, A. C., Sarmento‐Cabral, A., Guzmán‐Ruiz, R., Malagón, M. M., Herrera-Martínez, A. D., Gahete, M. D., & Luque, R. M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09838-w · Cited by 23
NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease
Zhang, J., Zeng, S., Wang, P., Chen, Y., & Zeng, C. (2023) · Current Drug Targets · doi:10.2174/0113894501255960231101105113 · Cited by 25
Chen, K., Li, B., Xu, H. F., Wu, J., Li, J., Sun, W., Fang, M., Wang, W., Wang, S., & Xiao, Z. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128388 · Cited by 23
Jing, B., Chen, Z., Si, W., Zhao, J., Zhao, G., & Zhang, D. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25372 · Cited by 23
“The Toll-like receptor 4/Nuclear factor kappa B (TLR4/ NF-κ B) pathway is involved in the initiation of inflammatory NLRP3 inflammasomes (Shao et al., 2015 ).”
Zinc homeostasis regulates caspase activity and inflammasome activation
Gong, X., Gu, W., Fu, S., Zou, G., & Jiang, Z. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012805 · Cited by 21
“Although targeting NLRP3 is a promising way, only a few inhibitors of NLRP3 inflammasome are currently available in clinical [62].”
IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse
Oike, T., Kanagawa, H., Sato, Y., Kobayashi, T., Nakatsukasa, H., Miyamoto, K., Nakamura, S., Kaneko, Y., Kobayashi, S., Harato, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34173-5 · Cited by 22
Zhang, T., Wang, H., Lü, M., Zhao, K., Yin, J., Liu, Y., & Sun, Y. (2020) · PubMed Central · Cited by 22
Wada, A., Higashiyama, M., Kurihara, C., Ito, S., Tanemoto, R., Mizoguchi, A., Nishii, S., Inaba, K., Sugihara, N., Hanawa, Y., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06848-z · Cited by 22
Wang, X., Yu, J., & Zhang, X. (2022) · Molecules · doi:10.3390/molecules27217637 · Cited by 22
Renal NLRP3 Inflammasome activation is associated with disease activity in lupus nephritis
Chen, F.-F., Liu, X.-T., Tao, J., Mao, Z., Wang, H., Tan, Y. C. R. S., Qu, Z., & Yu, F. (2023) · Clinical Immunology · doi:10.1016/j.clim.2022.109221 · Cited by 22
Wang, M., Zhang, F., Ning, X., Wu, C., Zhou, Y., Gou, Z., Yang, F., Duan, R., Li, Z., Shao, C., et al. (2023) · Inflammation · doi:10.1007/s10753-023-01885-4 · Cited by 23
“…and contains several special domains, such as the central nucleotide domain and oligomerization (NACHT), cysteine protease recruitment (CARD), leucine-rich repeat sequence (lrr), and hot protein (PYD) domains embedded with apoptosis-associated spot-like proteins (ASCs) and Caspase-1 [17, 18].”
BackgroundGu, Q., Xia, H., Song, Y.-Q., Duan, J., Chen, Y., You, Z., Chen, H., & Zhang, L. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i3.252 · Cited by 22
“This is activated in conditions of tissue damage, pathogen infection, and oxidative stress[12-14].”
Qi, H., Cao, Q., & Liu, Q. (2021) · Europe PMC (PubMed Central) · Cited by 22
Li, S., Li, Q., Zhou, Q., Li, S., Wang, S., Yao, Q., Ouyang, C., Liu, C., & Li, M. (2024) · Cardiovascular Therapeutics · doi:10.1155/2024/1506083 · Cited by 21
Self-citationBiological mechanisms of non-linear dose-response for respirable mineral fibers
Cox, L. A. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.06.016 · Cited by 21
Miao, B., Zheng, J., Zheng, G., Tian, X., Zhang, W., Yuan, F., & Yang, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.798708 · Cited by 21
Zhao, H., Sun, M., Zhang, Y., Kong, W., Fan, L., Wang, K., Xu, Q., Chen, B., Dong, J., Shi, Y., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0516 · Cited by 22
“In contrast, activation of NF-κB -related pathways mediated by NLRP3 inflammatory vesicles may reduce the polarity of AQP-4, which in turn leads to impaired normal function of the brain lymphatic system [14, 65, 165-168].”
Barsoumian, H. B., He, K., Hsu, E. Y., Bertolet, G., Sezen, D., Hu, Y. Y., Riad, T. S., Cortez, M. A., & Welsh, J. W. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03471-x · Cited by 21
“As shown, the release of DAMPs by radiation activates Toll-like receptors (TLRs), thereby inducing the activation of NF-kB and production of inactive NLRP3 building blocks, along with pro-IL-1 and proIL-18 [5, 44].”
BackgroundPotential roles of inflammasomes in the pathophysiology of Psoriasis: A comprehensive review
Shahi, A., Afzali, S., Amirzargar, A., Mohaghegh, P., Salehi, S., & Mansoori, Y. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.06.007 · Cited by 21
Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection
dos Reis, E. C., Leal, V. N. C., da Silva, L. T., dos Reis, M. M. L., Argañaraz, E. R., Oshiro, T. M., & Pontillo, A. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108266 · Cited by 21
Femminò, S., Pagliaro, P., & Penna, C. R. R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190325094453 · Cited by 20
A Novel Long-Noncoding RNA LncZFAS1 Prevents MPP+-Induced Neuroinflammation Through MIB1 Activation
Zhu, Z., Huang, P., Sun, R., Li, X., Li, W., & Gong, W. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02619-z · Cited by 20
“NLRP3 is regulated by both post-transcriptional and post-translational signals[18].”
BackgroundThe NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 20
“Considering all the information above, the NLRP3 inflammasome platform is already associated with the onset and/or progression of several diseases and disorders, including autoimmune, metabolic, cardiovascular, oncologic, neurodegenerative, psychiatric conditions, among others [27, 77, 118-127].”
Merighi, S., Nigro, M., Travagli, A., Pasquini, S., Borea, P. A., Varani, K., Vincenzi, F., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095056 · Cited by 23
Jiang, J., Kao, T.-C., Hu, S., Li, Y., Feng, W., Guo, X., Zeng, J., & Ma, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154777 · Cited by 20
Chang, Q.-X., Lyu, J.-L., Wu, P., Wen, K., Chang, C., & Chiang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512367 · Cited by 21
Sun, J., Wang, S., Zhao, Z., Lü, J., Zhang, Y., An, W., Li, W., Yang, L. C., & Tong, X. (2024) · Molecules · doi:10.3390/molecules29122897 · Cited by 20
“This initiates pyroptosis by generating GSDMD-N and damaging the integrity of the cell membrane, leading to the release of cleaved IL-1 β or interleukin-18 (IL-18) and causing inflammatory cell death [7].”
BackgroundRecent advances in the treatment of gout with NLRP3 inflammasome inhibitors
Tian, Y., He, X., Li, R., Wu, Y., Ren, Q., & Hou, Y. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117874 · Cited by 20
An overview of disease models for NLRP3 inflammasome over-activation
Zhang, H., Zahid, A., Ismail, H., Tang, Y., Jin, T., & Tao, J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1844179 · Cited by 20
“OLT1177 Human blood-derived macrophages, Human blood neutrophils, Monocytes isolated from patients with CAPS, Spleen cells from mice [43]”
BackgroundMiR-494-3p alleviates acute lung injury through regulating NLRP3 activation by targeting CMPK2
Wang, H., Wang, S., & Huang, S. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0243 · Cited by 19
Fei, J., Xiao, Q., Ma, H., Zhang, X., Wang, H., Han, J., Yu, C., & Jiang, J. (2022) · Inflammation · doi:10.1007/s10753-022-01689-y · Cited by 19
“NLRP3 assembles with linker molecules and effector molecules (caspase-1) to form NLRP3 inflammasomes [4].”
BackgroundInteraction Between Autophagy and Porphyromonas gingivalis-Induced Inflammation
Kang, S., Dai, A., Wang, H., & Ding, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.892610 · Cited by 20
Yan, J., Feng, G., Yang, Y., Ding, D., Ma, L., Zhao, X. S., Chen, X., Wang, H., Chen, Z., & Jin, Q. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2022.7677 · Cited by 20
“C-terminal caspase recruitment domain (ASC) and the cysteine protease caspase-1 [6].”
BackgroundPost-phagocytosis activation of NLRP3 inflammasome by two novel T6SS effectors
Cohen, H., Baram, N., Fridman, C. M., Edry‐Botzer, L., Salomon, D., & Gerlic, M. (2022) · eLife · doi:10.7554/elife.82766 · Cited by 19
Xie, M., Wang, H., Peng, J., Qing, D., Zhang, X., Guo, D., Meng, P., Luo, Z., Wang, X., & Peng, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.984475 · Cited by 19
“In the presence of immune activators such as pathogen-associated molecular patterns (PAMPs), danger-associated molecular patterns (DAMPs), or other exogenous invaders, the pyrin domains of NLRP3 binds to that of ASC, and subsequently the caspase recruitment domain of ASC recruits and interacts with pro-caspase-1 (Shao…”
BackgroundZhang, C., Huang, W., Zhang, X., Li, P., Wang, C., Ye, L., Xu, Z., Yuan, J., & Yu, H. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.740973 · Cited by 19
Self-citationO’Donovan, D. H., Mao, Y., & Mele, D. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190620103105 · Cited by 19
Wang, X., Huang, H., Su, C., Zhong, Q., & Wu, G. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1665058 · Cited by 19
“NLRP3 inflammasome inhibitors exist but have been shown to be largely ineffective in clinical settings [5].”
BackgroundVibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome
Cohen, H., Baram, N., Edry‐Botzer, L., Munitz, A., Salomon, D., & Gerlic, M. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1720526 · Cited by 19
Fu, C., Zhang, X., Zeng, Z., Tian, Y., Jin, X., Wang, F., Xu, Z., Chen, B., Zheng, H., & Liu, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00065 · Cited by 19
“Inflammasome as a newly identified pattern-recognition receptors, was firstly described in detail by Martinon in 2002 (Martinon et al., 2002; Shao et al., 2015).”
BackgroundSelf-citationPicroside II protects against sepsis via suppressing inflammation in mice.
(2016) · PubMed Central · Cited by 19
Can we use interleukin-1β blockade for lung cancer treatment?
Gottschlich, A., Endres, S., & Kobold, S. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.03.15 · Cited by 19
“The inflammasome-dependent, caspase-mediated cleavage of pro-IL-1β broadens the spectrum of poss ible pharmacological targets (21).”
BackgroundYang, L., Lu, P., Qi, X., Yang, Q., Liu, L., Dou, T., Guan, Q., & Yu, C. (2023) · iScience · doi:10.1016/j.isci.2023.108082 · Cited by 20
Xu, H., He, T., Chen, S.-Y., Shi, R., Xu, J., Xing, Y.-R., Shi, D., Liu, Y.-Q., He, B.-S., & Gu, J. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103803 · Cited by 18
Bertesi, M., Fantini, S., Alecci, C., Lotti, R., Martello, A., Parenti, S., Carretta, C., Marconi, A., Grande, A., Pincelli, C., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.579383 · Cited by 18
“The inflammasome also plays a role in a number of psoriasis-related comorbidities such as metabolic syndrome, atherosclerosis, and cardiovascular disease (20).”
BackgroundMohamed, R. A., Abdallah, D. M., El-Brairy, A. I., Ahmed, K. A., & El-Abhar, H. S. (2021) · Molecules · doi:10.3390/molecules26165068 · Cited by 18
ElMahdy, M. K., Antar, S. A., Elmahallawy, E. K., Abdo, W. S., Hijazy, H. H. A., Albrakati, A., & Khodir, A. E. (2021) · Biomedicines · doi:10.3390/biomedicines10010040 · Cited by 18
Ning, W., Gao, G., Zhou, Y., Li, W., Yang, H., Duan, X.-B., Li, X., Gong, Y.-B., Li, D., & Guo, R. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109747 · Cited by 19
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
Wang, X., Lin, J., Wang, Z., Li, Z., & Wang, M. (2023) · Discover Oncology · doi:10.1007/s12672-023-00701-7 · Cited by 20
“Through CRISPR/Cas9 gene editing, NLRP3 can be eliminated directly at the genomic level [118].”
BackgroundFu, R., Guo, X., Pan, Z., Wang, Y., Xu, J., Zhang, L., & Li, J. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04200-x · Cited by 18
“…or danger signals, the NLRP3 inflammasome has played critical roles in various disease processes, being implicated in the onset and progression of diseases such as diabetes, obesity, rheumatoid arthritis, Alzheimer’s disease, Parkinson’s disease, and other autoimmune and inflammatory diseases [10].”
BackgroundLi, W.-X., Yu, L. S., Chi, J.-B., Wang, J., Liu, Y., Wang, C., Zhang, M., & Hou, G. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116284 · Cited by 18
Yuan, C., Liu, L., Zhao, Y., & Wang, K. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18550 · Cited by 18
“11 In addition, NLRP3 is also involved in other chronic inflammatory diseases, such as gout or atherosclerosis.”
BackgroundCristo, L. D., Carthy, S. M., Paton, K. R., Movia, D., & Prina‐Mello, A. (2018) · 2D Materials · doi:10.1088/2053-1583/aadf45 · Cited by 18
“It is well know that autophagy inhibits the inflammasome activation [39].”
BackgroundSunasee, R., Carson, M., Despres, H. W., Pacherille, A., Nunez, K. D., & Ckless, K. (2019) · Journal of Nanomaterials · doi:10.1155/2019/4751827 · Cited by 18
“Activation of the NLRP3 inflammasome plays an important role in innate immunity, and the inflammatory response and the secretion of IL-1β by immune cells can be indicative of this immunological response [34, 35].”
BackgroundJiao, P., Li, W., Shen, L., Li, Y., Yu, L., & Liu, Z. (2020) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2020.1730391 · Cited by 18
Komleva, Y. K., Lopatina, O. L., Gorina, Y. V., Черных, А. И., Труфанова, Л. В., Vais, E. F., Kharitonova, E. V., Жуков, Е. Л., Vahtina, L. Y., Медведева, Н. Н., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01021-y · Cited by 18
High-fat Feeding Causes Inflammation and Insulin Resistance in the Ventral Tegmental Area in Mice
Mizoguchi, A., Banno, R., Sun, R., Yaginuma, H., Taki, K., Kobayashi, T., Sugiyama, M., Tsunekawa, T., Onoue, T., Takagi, H., et al. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.02.009 · Cited by 20
Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease
Hemenway, G., & Frishman, W. H. (2021) · Cardiology in Review · doi:10.1097/crd.0000000000000391 · Cited by 18
“a diarylsulfonylurea-containing small molecule inhibitor that blocks ASC oligomerization.(5) In both mouse models and ex vivo human”
InfluentialZhang, H., Luan, S., Xiao, X., Lin, L., Zhao, X., & Liu, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118850 · Cited by 17
RetractedLi, G., Zong, X., Cheng, Y., Xu, J., Deng, J., Huang, Y., Ma, C., & Fu, Q. (2022) · Veterinary Microbiology · doi:10.1016/j.vetmic.2022.109430 · Cited by 17
Bao, X., Zu, Y., Wang, B., Li, M., Jiang, F., Qian, C., Zhou, F., & Ding, Z. (2023) · Environmental Toxicology · doi:10.1002/tox.23772 · Cited by 17
Chen, X., Li, W., & Chang, C. (2023) · Autoimmunity · doi:10.1080/08916934.2023.2189135 · Cited by 17
“As for inflammation, the NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome has also been demonstrated to be implicated in various auto-immune and auto-inflammatory diseases [10].”
BackgroundLiu, B., Wu, Y., Liang, T., Zhou, Y., Chen, G., He, J., Ji, C., Liu, P., Zhang, C., Lin, J., et al. (2023) · Mediators of Inflammation · doi:10.1155/2023/3706421 · Cited by 17
“Specifically, NLRP3 inflammasome activates caspase-1, causing maturation of pro-inflammatory IL-1β and IL-18 cytokines into their respective active forms, leading to further inflammatory responses [49, 50].”
Jiang, Y., Dong, B., Xing, J., Shan, J., Fang, C., Zhang, K., Li, D., Xu, C., & Zhang, Z. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170129 · Cited by 17
The significance of targeting lysosomes in cancer immunotherapy
Xu, Y., Shao, B., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1308070 · Cited by 21
Self-citationTMAO is involved in kidney-yang deficiency syndrome diarrhea by mediating the “gut-kidney axis”
Xie, S., Deng, N., Fang, L., Shen, J., Tan, Z., & Cai, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35461 · Cited by 18
“Upon activation, macrophages release various cytokines, including IL-1 β and TGF-β 1 signaling the onset of fibrosis, which frequently occurs with organ inflammatory disorders [44,45].”
BackgroundQin, F., Wang, F., Wang, C., Chen, Y., Li, M.-S., Zhu, Y.-K., Huang, X., Fan, C.-W., & Wang, H. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.104990 · Cited by 17
Liu, H., Bian, Z., Zhang, Q., Xiao, Z., Cao, Y., Sun, X., Qin, Y., Mao, L., Chu, X., Liao, W., et al. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104862 · Cited by 18
A narrative review of positive regulation of NLRP3 inflammasome in rheumatoid arthritis.
Zhuang, Y.-P., Wang, H., Su, J., Zhang, J., Wang, Q., Chen, Y.-N., & Che, H. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-3472 · Cited by 15
“The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is the most widely studied (20), and triggers host autoimmune defenses by recognizing foreign danger signals.”
BackgroundNielsen, A. E., Hantho, J. D., & Mancini, R. J. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0101 · Cited by 17
Lei, S., Liu, K., Liu, C., An, R., Bao, Z., Zhang, H., Zou, M., Chen, J., Zhang, H., Wei, L., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157145 · Cited by 16
Self-citationASC modulates HIF-1α stability and induces cell mobility in OSCC
Wu, C., Chang, I. Y., Hung, J.-L., Liao, W., Lai, Y.-R., Chang, K., Li, H., & Chang, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02927-7 · Cited by 19
Chen, H. H., Qiao, H., Zhao, Q., & Wei, F. (2022) · Bioengineered · doi:10.1080/21655979.2021.2024956 · Cited by 16
Wei, B., Wu, Q., Xuexia, Y., Lai, C., Zhou, S., & Liang, Z. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101792 · Cited by 16
Li, J.-S., Su, S., Xu, Z., Zhao, L.-H., Fan, R.-Y., Guo, J., Qian, D., & Duan, J. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221091177 · Cited by 18
Self-citationAzumi, J., Shimada, Y., Takeda, T., Aso, H., & Nakamura, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113364 · Cited by 16
Zhu, X., Liu, H., Wang, D., Guan, R., Zou, Y., Li, M., Zhang, J., & Chen, J. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114828 · Cited by 16
HIV-Related Atherosclerosis: State-of-the-Art-Review
Арманович, А. А., Вачиковна, П. Н., Kakturskiy, L., Sheibani, M., Urazova, O. I., Трофименко, А. И., Navarsdyan, G., Jndoyan, Z., Abgaryan, K., Fogacci, F., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101783 · Cited by 16
Xu, X., Zhou, B., Liu, J., Ma, Q., Zhang, T., & Wu, X. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s409568 · Cited by 16
“The activated NLRP3 inflammasome triggers the cleavage of the pro-caspase-1 to caspase-1, which is then released into the cytoplasm to further induce the conversion of the pro- IL-1β to active IL-1β (Figure 7).(29) There is a high concentration of inflammatory cytokine receptors in regions related to learning and memo…”
BackgroundQi, J., Jin, Y., Wang, X., Yang, L.-K., Lu, L., Yue, J., Yang, F., Liu, Y., Jiang, Y., Song, D., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8325 · Cited by 16
“The NLRP3 inflammasome plays an important role in inflammation and immunity (Shao et al. 2015).”
The application of procyanidins in diabetes and its complications: a review of preclinical studies
Zhang, Y., Li, M., Liu, H., Fan, Y., & Liu, H. H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1532246 · Cited by 17
New molecular targets for the treatment of sarcoidosis
Chiarchiaro, J., Chen, B. B., & Gibson, K. F. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000304 · Cited by 15
PM2.5 induce myocardial injury in hyperlipidemic mice through ROS-pyroptosis signaling pathway
Jia, R., Wei, M., Lei, J., Meng, X., Du, R., Yang, M., Lu, X., Jiang, Y., Cao, R., Wang, L., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114699 · Cited by 15
Morillo-Bargues, M. J., Osorno, A. O., Guerri, C., Pradas, M. M., & Martínez‐Ramos, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210340 · Cited by 15
Piotrowska, K., Zgutka, K., Tkacz, M., & Tarnowski, M. (2023) · Antioxidants · doi:10.3390/antiox12081488 · Cited by 18
“Khakroo Abkenar et al. [115] showed that chronic exercise with moderate intensity significantly reduced the expression of the NLRP3 gene and serum levels of IL-1β and IL-18 in a group of healthy, young men.”
BackgroundInfluentialGojani, E. G., Wang, B., Li, D., Kovalchuk, O., & Kovalchuk, I. (2023) · Molecules · doi:10.3390/molecules28227619 · Cited by 15
Neutrophil extracellular traps in central nervous system (CNS) diseases
Shao, B., Jiang, J., Zhao, Y.-C., Zheng, X.-R., Xi, N., Zhao, G.-R., Huang, X., & Wang, S. (2024) · PeerJ · doi:10.7717/peerj.16465 · Cited by 15
“…kinds of inflammasomes have been reported, namely NOD-like receptor family, pyrin domain-containing (NLRP)1, NLRP2, NLRP3, NLR family caspase recruitment domain-containing protein 4 (NLRC4), and double-stranded DNA sensors absent in melanoma 2 (AIM2) ( Shao, Cao & Liu, 2018 ; Shao et al., 2015 ).”
BackgroundSelf-citationHuang, W., Wang, C., & Zhang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24401 · Cited by 15
“NLRP3 inflammasome, includes NLRP3, ASC, caspase-1, IL-1 β , and IL-18 proteins, and its activation is involved in the HCC progression [42 – 44].”
BackgroundLi, J., Wang, X., Bai, J., Wei, H., Wang, W., & Wang, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04877-6 · Cited by 15
“Nuclear factor kappa B (NF-κB) signaling is triggered in one way [9], while certain chemicals, such as mitochondrial reactive oxygen species, may activate a second signal [10].”
BackgroundFu, Q., Zhang, J., Zhu, Q., Ling-ling, Y., Wang, F., Li, J., He, X. J., Ao, J.-L., Xu, G., Wei, M.-C., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150038 · Cited by 16
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis
Karmakar, V., Chain, M., Majie, A., Ghosh, A., Sengupta, P., Dutta, S., Mazumder, P. M., & Gorain, B. (2025) · Inflammopharmacology · doi:10.1007/s10787-024-01629-2 · Cited by 18
“2) and brings NLRP3, ASC, and procaspase-1 together (Shao et al. 2015).”
Zuo, D., Do, N., Hwang, I., Ann, J., Yu, J.-W., & Lee, J. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128693 · Cited by 10
Metadata
- Authors
- Shao, B.-Z., Xu, Z.-Q., Han, B.-Z., Su, D.-F., & Liu, C.
- Affiliations
- Second Military Medical University (CN)
- Corresponding author
- Liu, Chong
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2015-11-05
- Volume
- 6
- Pages
- 262-262
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC4633676
- OpenAlex
- W2137444266
- Cited by
- 836
- References
- 115
- Citations by year
- 2026: 42 · 2025: 62 · 2024: 102 · 2023: 107 · 2022: 114 · 2021: 105 · 2020: 91 · 2019: 68 · 2018: 61 · 2017: 57 · 2016: 24 · 2015: 2
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Frontiers in Pharmacology (cc-by)
- Funders
- Natural Science Foundation of Shanghai (13ZR1448400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Keywords
- NLRP3 inflammasome, inflammasome inhibitors, innate immunity, autoinflammatory disease, autoimmune disease, metabolic disorders, multiple sclerosis, inflammatory bowel disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review